Annual report pursuant to Section 13 and 15(d)

Leases

Leases

12 Months Ended

Dec. 31, 2022

As of December 31, 2022, the maturities of the operating lease liabilities and a reconciliation to the present value of lease liabilities were as follows (in thousands):


	Remaining Lease Payments
2023	$	9,235
2024	9,769
2025	7,939
2026	6,941
2027	6,857
Thereafter	56,026
Total remaining lease payments	96,767
Less: imputed interest	(21,231)
Total operating lease liabilities	75,536
Less: current portion	(6,584)
Long-term operating lease liabilities	$	68,952
Weighted-average remaining lease term (in years)	12.33
Weighted-average discount rate	3.7		%

The following summarizes additional supplemental data related to the operating leases for the years ended December 31, 2022 and 2021 (in thousands):


	2022		2021
Operating lease costs	$	13,135	$	11,231
Right-of-use assets obtained in exchange for operating lease liabilities	$	9,149	$	39,785
Cash paid for operating leases	$	11,222	$	10,165

In 2021, the Company’s lease of its new laboratory and headquarters facility in Fort Myers, Florida commenced. As of December 31, 2021, the Company had paid approximately $25.0 million to the landlord for the construction of the underlying assets which was classified as a prepaid lease asset until the lease commenced in the third quarter of 2021 at which time the prepaid lease asset was included in the calculation of the right-of-use asset. There were no such amounts recorded for the year ended December 31, 2022. As of December 31, 2021, the Company had paid approximately $17.0 million to the landlord for leasehold improvements, which are included in property and equipment, net, for its new laboratory and headquarters facility. As of December 31, 2021, all disbursements to the landlord had been completed.